Bill Texts: NJ AR130 | 2014-2015 | Regular Session

Bill Title: Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2014-06-05 - Introduced, Referred to Assembly Health and Senior Services Committee [AR130 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2014-06-05HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey AR130

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey AR130 currently on file.

Social Comments on NJ AR130

feedback